JKL 1073A

Drug Profile

JKL 1073A

Latest Information Update: 17 Nov 2003

Price : $50

At a glance

  • Originator National Taiwan University
  • Class Antiarrhythmics; Cardiotonics; Small molecules
  • Mechanism of Action Potassium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arrhythmias

Most Recent Events

  • 17 Nov 2003 Discontinued - Preclinical for Arrhythmias in Taiwan (unspecified route)
  • 04 Mar 1998 A study has been added to the pharmacodynamics section
  • 10 Sep 1996 Preclinical development for Arrhythmias in Taiwan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top